| Code | 03796 | ||||||||||
| MA number | 68/0009/77-S | ||||||||||
| Product Form: | tbl 20x50 mg (fľ.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 21.04.1977 |
| PIL: |
PIL_Grandaxin_08_2023.pdf
|
| SPC: |
SPC_Grandaxin_05_2024.pdf
|
| Safety feature | Yes |
| Data update: | 03.05.2024 |
